|
Hynic-rh-Annexin V
Description: Recombinant human Hynic-Annexin V prepared
in E. coli and provided as 0.275 mg/vial.
Concentration: 0.5 mg/ml
Volume: 0.55 ml
Buffer: 115 mM tricine, pH 6 (+/- 1.0)
Accompanying Reagents: Stannous tricine buffer provided
as a lyophilized powder consisting of 500 ug stannous chloride dehydrate and 20
mg tricine, pH 6.0. Each vial is to be reconstituted with 1.0 ml of sterile saline
for injection (0.9%). Reconstituted solution is stable for one hour.
Product Testing:
Sterility: Sterile filtered.
Mycoplasma: Negative
Endotoxin: <4 EU/mg
Product Storage : -80oC
Reference: Lahorte, CMM, Vanderheyden, J-L, Steimetz,
N, Van de Wiele, C, Dierckx, RA, and Slegers, G. (2004) Eur J Nucl Med & Molec
Imaging 31:887.
Additional Instructions
CAUTION:FOR NON-CLINICAL RESEARCH USE ONLY. NOT FOR USE IN HUMANS.
NOTE: Recipients of repository reagents will be required to sign a Material
Transfer Agreement. All International Orders are required to pay a packaging and
handling fee. All recipients are required to providea a FedEx account number.
All recipients are required to pay for shipping.
|